The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover
Abstract
The c-myc proto-oncogene encodes a short-lived transcription factor that plays an important role in cell cycle regulation, differentiation and apoptosis. c-myc is often rearranged in tumors resulting in deregulated expression. In addition, mutations in the coding region of c-myc are frequently found in human lymphomas, a hot spot being the Thr58 phosphorylation site, a mutation shown to enhance the transforming capacity of c-Myc. It is, however, still unclear in what way this mutation affects c-Myc activity. Our results show that proteasome-mediated turnover of c-Myc is substantially impaired in Burkitt's lymphoma cells with mutated Thr58 or other mutations that abolish Thr58 phosphorylation, whereas endogenous or ectopically expressed wild type c-Myc proteins turn over at normal rates in these cells. Myc Thr58 mutants expressed ectopically in other cell types also exhibit reduced proteasome-mediated degradation, which correlates with a substantial decrease in their ubiquitination. These results suggest that ubiquitin/proteasome-mediated degradation of c-Myc is triggered by Thr58 phosphorylation revealing a new important level of control of c-Myc activity. Mutation of Thr58 in lymphoma thus escapes this regulation resulting in accumulation of c-Myc protein, likely as part of the tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529
Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., & Rolfe, M. (1995) · Science · doi:10.1126/science.7624798 · Cited by 1,817
UBIQUITIN-DEPENDENT PROTEIN DEGRADATION
Hochstrasser, M. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.405 · Cited by 1,692
Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
Treier, M., Staszewski, L. M., & Bohmann, D. (1994) · Cell · doi:10.1016/s0092-8674(94)90502-9 · Cited by 923
Marcu, K. B., Bossone, S. A., & Patel, A. J. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.004113 · Cited by 802
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
Serine Phosphorylation-regulated Ubiquitination and Degradation of β-Catenin
Orford, K., Crockett, C., Jensen, J. P., Weissman, A. M., & Byers, S. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24735 · Cited by 714
Evolution of tumours and the impact of molecular oncology
Klein, G., & Klein, E. (1985) · Nature · doi:10.1038/315190a0 · Cited by 661
Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1
Tomoda, K., Kubota, Y., & Kato, J.-Y. (1999) · Nature · doi:10.1038/18230 · Cited by 632
Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.
Hann, S. R., & Eisenman, R. N. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.11.2486 · Cited by 495
Alvarez, E., Northwood, I. C., Gonzalez, F. A., Latour, D. A., Seth, A., Abate, C., Curran, T., & Davis, R. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98613-8 · Cited by 472
Ras Enhances Myc Protein Stability
Sears, R., Leone, G., DeGregori, J., & Nevins, J. R. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80308-1 · Cited by 460
Salghetti, S. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.717 · Cited by 443
Degradation of nuclear oncoproteins by the ubiquitin system in vitro.
Ciechanover, A., DiGiuseppe, J. A., Bercovich, B., Orian, A., Richter, J. D., Schwartz, A. L., & Brodeur, G. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.139 · Cited by 339
Bhatia, K., Huppi, K., Spangler, G., Siwarski, D., Iyer, R., & Magrath, I. (1993) · Nature Genetics · doi:10.1038/ng0993-56 · Cited by 285
Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma
Rabbitts, T. H., Hamlyn, P. H., & Baer, R. (1983) · Nature · doi:10.1038/306760a0 · Cited by 281
Binding and Suppression of the Myc Transcriptional Activation Domain by p107
Gu, W., Bhatia, K., Magrath, L. T., Dang, C. V., & Dalla-Favera, R. (1994) · Science · doi:10.1126/science.8146655 · Cited by 235
Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo.
Pulverer, B., Fisher, C., Vousden, K. H., Littlewood, T. D., Evan, G. I., & Woodgett, J. R. (1994) · PubMed · Cited by 228
Lutterbach, B., & Hann, S. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5510 · Cited by 220
Gross-Mesilaty, S., Reinstein, E., Bercovich, B., Tobias, K. E., Schwartz, A. L., Kahana, C., & Ciechanover, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8058 · Cited by 177
Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential.
Henriksson, M., Bakardjiev, A. I., Klein, G., & Lüscher, B. (1993) · PubMed · Cited by 162
Hoang, A. T., Lutterbach, B. A., Lewis, B. C., Yano, T., Chou, T., Barrett, J. F., Raffeld, M. A., Hann, S., & Dang, C. V. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4031 · Cited by 139
Flinn, E. M., Busch, C. M. C., & Wright, A. P. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5961 · Cited by 131
Targeted Degradation of c-Fos, But Not v-Fos, by a Phosphorylation-Dependent Signal on c-Jun
Papavassiliou, A. G., Treier, M., Chavrier, C., & Bohmann, D. (1992) · Science · doi:10.1126/science.1470918 · Cited by 110
Showe, L. C., Ballantine, M., Nishikura, K., Erikson, J., Kaji, H., & Croce, C. M. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.3.501 · Cited by 108
Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.
Yano, T., Sander, C. A., Clark, H. M., Dolezal, M. V., Jaffe, E. S., & Raffeld, M. A. (1993) · PubMed · Cited by 101
Lessons from the discovery ofthe ubiquitin system
Hershko, A. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10054-2 · Cited by 92
Bhatia, K. G., Spangler, G., Gaïdano, G., Hamdy, N., Dalla‐Favera, R., & Magrath, I. T. (1994) · Blood · doi:10.1182/blood.v84.3.883.883 · Cited by 88
Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas.
Clark, H. M., Yano, T., Otsuki, T., Jaffe, E. S., Shibata, D., & Raffeld, M. A. (1994) · PubMed · Cited by 73
Albert, T., Urlbauer, B., Kohlhuber, F., Hammersen, B., & Eick, D. (1994) · PubMed · Cited by 66
In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasome
Bonvini, P., Nguyen, P., Trepel, J. B., & Neckers, L. Μ. (1998) · Oncogene · doi:10.1038/sj.onc.1201625 · Cited by 55
Sequence curiosity in v-myc oncogene
Papas, T. S., & Lautenberger, J. A. (1985) · Nature · doi:10.1038/318237a0 · Cited by 50
The transforming activity of the chicken c-myc gene can be potentiated by mutations.
Frykberg, L., Graf, T., & Vennström, B. (1987) · PubMed · Cited by 45
Larsson, L.-G., Bahram, F., Burkhardt, H., & Lüscher, B. (1997) · Oncogene · doi:10.1038/sj.onc.1201390 · Cited by 44
Self-citationSymonds, G. P., Hartshorn, A., Kennewell, A., O'Mara, M. A., Bruskin, A. M., & Bishop, J. M. (1989) · PubMed · Cited by 36
Bahram, F., Wu, S., Oberg, F. G., Lüscher, B., & Larsson, L. (1999) · Blood · doi:10.1182/blood.v93.11.3900 · Cited by 32
Self-citationAxelson, H., Arsenian‐Henriksson, M., Wang, Y., Magnusson, K. P., & Klein, G. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00449-1 · Cited by 18
Cited by
Transcriptional regulation and transformation by Myc proteins
Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,131
Welcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084
Welcker, M., Orian, A., Jin, J., Grim, J. A., Harper, J. W., Eisenman, R. N., & Clurman, B. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402770101 · Cited by 941
Miller, D. M., Thomas, S. D., Islam, A., Muench, D., & Sedoris, K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0977 · Cited by 847
Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7
Yada, M., Hatakeyama, S., Kamura, T., Nishiyama, M., Tsunematsu, R., Imaki, H., Ishida, N., Okumura, F., Nakayama, K., & Nakayama, K. I. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600217 · Cited by 808
Metadata
- Authors
- Bahram, F., von der Lehr, N., Cetinkaya, C., & Larsson, L.-G.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2000-03-15
- Volume
- 95
- Issue
- 6
- Pages
- 2104-2110
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W8121613
- Cited by
- 286
- References
- 37
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.